AC-301

N/A

Report date: 2025/07/18 11:49:38
NMEFirst In Class

Base Information

Drug NameAC-301
Drug Alias NameAC-301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammationLymphoma, Large B-Cell, DiffuseLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAccro Bioscience (Suzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAccro Bioscience (Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammationLymphoma, Large B-Cell, DiffuseLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A